(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EMERYGLIDE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EMERYGLIDE

ST13

US500000079282880

Class

5, 10, 44

Filing

79282880

Registration

6465619

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

12/29/2023

Trademark type

Word

Nice classes

5, 10, 44

Filing date

02/07/2020

Registration date

08/31/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/31/2021

Last transaction

08/31/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

DE

Examiner

MASON,JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Nano4Imaging GmbH

Representatives

Teige P. Sheehan Heslin Rothenberg Farley & Mesiti P.C.

Technical classification

Nice Classes

Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Radiological contrast substances for medical diagnosticsfor imaging structures and functions of tissue or organs in the human or animal body; radiological contrast substancesfor assessment of human or animal organs; radiological contrast substancesfor use with magnet resonance imaging; radiological or MRI contrast substancesfor imaging for medical purposes; paramagnetic contrast substancesfor medical or veterinary purposes; medical diagnostic reagents in the nature of fluids based on hemins for medical analysis of imaging in connection with magnet resonance imaging and radiological diagnostics; medical diagnostic reagents in the nature of fluids based on paramagnetic nanodots for medical and veterinary purposes; paramagnetic pharmaceutical preparations and paramagnetic nanodots being preparations for in-vitro diagnostics; paramagnetic pharmaceutical preparations and paramagnetic nanodots being preparations for in-vivo diagnostics; magnetic resonance markers being preparations for therapeutic or diagnostic medical use

Class 10

Surgicalmedical and veterinary apparatus and instruments for use in medical analysis of imaging in connection with magnet resonance imaging and radiological diagnostics; medical apparatus and instruments for monitoring blood properties and respiratory events; apparatus for use in medical and veterinary analysis of electrolytes in the body

Class 44

Medical servicesnamely artificial liver support for human beings and animalsprovided by persons or companies; medical analysis for treatment and diagnostic purposes provided by medical laboratories in relation to imaging in connection with magnet resonance imaging and radiological diagnostics including MRI scans

Publications

History of USPTO decisions and trademark events.

35 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/29/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/27/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/07/2022

FIMP

FINAL DISPOSITION PROCESSED

02/07/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/30/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/31/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/15/2021

PUBO

PUBLISHED FOR OPPOSITION

06/15/2021

GPNX

NOTIFICATION PROCESSED BY IB

06/13/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/26/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/26/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/26/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/13/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

05/13/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/13/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

05/13/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/13/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/14/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/13/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

04/13/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/03/2020

GNFR

FINAL REFUSAL E-MAILED

12/03/2020

CNFR

FINAL REFUSAL WRITTEN

12/03/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/11/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/10/2020

RFNT

REFUSAL PROCESSED BY IB

05/29/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/10/2020

RFRR

REFUSAL PROCESSED BY MPU

05/09/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/28/2020

CNRT

NON-FINAL ACTION WRITTEN

04/27/2020

DOCK

ASSIGNED TO EXAMINER

04/27/2020

MAFR

APPLICATION FILING RECEIPT MAILED

04/17/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/13/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/09/2020

Continuous trademark protection

Get notified about every new filing that threatens EMERYGLIDE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.